Adia Med ADIA
OTC ADIA
$0.13 +0.01 (+8.33%)
At close: Nov 10, 2026 · 4:00 PM EST

Adia Med (ADIA) Capital Expenditures (2025 - 2026)

Updated

Adia Nutrition (ADIA) recorded Capital Expenditures of $5,494 in Q1 2026.

Analysis

Adia Med (ADIA) Capital Expenditures (2025 - 2026) Analysis & Trends

For FY2025, Adia Nutrition reported Capital Expenditures of $13,200, down 39.5% from FY2024.

  • Across earlier years, Capital Expenditures came in at $21,831 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 3.18 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 1.36 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 301.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 1.04 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -3.30 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 587.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 237.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 573.00 Mn
10 Adia Med 12.27 Mn 11.92 Mn 282,580.00 -10,989.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -10,989.00
Mar 31, 2026 5,494.00
Jun 30, 2025 -13,199.00
API Access

Adia Med Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ADIA&period=max&api_key=YOUR_API_KEY